Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | neuroendocrine convertase 2 | 0.0091 | 0.4087 | 0.1038 |
Schistosoma mansoni | subfamily S8B unassigned peptidase (S08 family) | 0.0144 | 1 | 1 |
Echinococcus granulosus | neuroendocrine convertase 2 | 0.0091 | 0.4087 | 0.0526 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0088 | 0.3758 | 0.5 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0088 | 0.3758 | 0.5 |
Giardia lamblia | High cysteine membrane protein Group 2 | 0.0054 | 0 | 0.5 |
Echinococcus multilocularis | 0.0116 | 0.6922 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0144 | 1 | 1 |
Loa Loa (eye worm) | endoprotease bli-4 | 0.0144 | 1 | 1 |
Brugia malayi | celfurPC protein | 0.0116 | 0.6922 | 0.4795 |
Echinococcus granulosus | furin | 0.0144 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | Agonist activity at human GABAA alpha1beta2gamma2S receptor expressed in TSA201 cells at 300 to 500 uM after 1 min by FLIPR assay | ChEMBL. | 23294161 | |
Activity (binding) | Agonist activity at human GABAA rho1 receptor expressed in TSA201 cells at 300 to 500 uM after 1 min by FLIPR assay | ChEMBL. | 23294161 | |
EC50 (binding) | > 500 uM | Agonist activity at human GABAA rho1 receptor expressed in TSA201 cells after 1 min by FLIPR assay | ChEMBL. | 23294161 |
EC50 (binding) | > 500 uM | Agonist activity at human GABAA alpha1beta2gamma2S receptor expressed in TSA201 cells after 1 min by FLIPR assay | ChEMBL. | 23294161 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.